- Home
- ACI vs PEN Comparison
ACI vs PEN Comparison
Compare ACI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- PEN
- Stock Information
- Founded
- ACI 1860
- PEN 2004
- Country
- ACI United States
- PEN United States
- Employees
- ACI 285000
- PEN N/A
- Industry
- ACI Food Chains
- PEN Medical/Dental Instruments
- Sector
- ACI Consumer Staples
- PEN Health Care
- Exchange
- ACI Nasdaq
- PEN Nasdaq
- Market Cap
- ACI 10.5B
- PEN 10.6B
- IPO Year
- ACI 2020
- PEN 2015
- Fundamental
- Price
- ACI $18.53
- PEN $271.72
- Analyst Decision
- ACI Strong Buy
- PEN Strong Buy
- Analyst Count
- ACI 14
- PEN 16
- Target Price
- ACI $24.79
- PEN $302.93
- AVG Volume (30 Days)
- ACI 5.2M
- PEN 471.2K
- Earning Date
- ACI 10-14-2025
- PEN 10-29-2025
- Dividend Yield
- ACI 3.20%
- PEN N/A
- EPS Growth
- ACI N/A
- PEN 916.05
- EPS
- ACI 1.64
- PEN 3.74
- Revenue
- ACI $81,006,300,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- ACI $4.92
- PEN $15.52
- Revenue Next Year
- ACI $0.67
- PEN $14.20
- P/E Ratio
- ACI $11.42
- PEN $72.95
- Revenue Growth
- ACI 1.96
- PEN 12.92
- 52 Week Low
- ACI $17.00
- PEN $184.80
- 52 Week High
- ACI $23.20
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ACI 35.59
- PEN 55.43
- Support Level
- ACI $18.42
- PEN $270.54
- Resistance Level
- ACI $18.79
- PEN $280.14
- Average True Range (ATR)
- ACI 0.33
- PEN 7.24
- MACD
- ACI -0.03
- PEN -0.72
- Stochastic Oscillator
- ACI 8.14
- PEN 36.14
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.